baber/WOPTO huggingface dataset:
Patent IE-49808-B1 (IE)
Title: Liquid fuel composition and a method of preparing such a composition
IPC: C09K23/52
Filed: 1980-05-19
Abstract: A liquid fuel composition consisting of a stable emulsion of (a) a mineral fuel oil, (b) methanol or an aqueous solution of methanol, saccharose or a starch decomposition product, and (c) a polymeric emulsifier. The fuel composition is prepared by emulsifying the three components in a homogenizer or an ultrasonic generator. The fuel composition has a viscosity of the same order as that of the mineral fuel oil and the utilization of calories contained in the fuel composition is higher than that of pure mineral fuel oil when used as a fuel for a diesel engine. A polymeric emulsifier is prepared by esterifying a naturally occurring polymer containing free hydroxy groups with a fatty acid or with a condensation product of a hydroxy fatty acid.
Patent IE-55175-B1 (IE)
Title: Freeze dried microfibrillar cellulose
IPC: D21C9/00
Filed: 1984-05-04
Abstract: An absorbent retentive cellulosic pulp comprising sheets or platelets (10) of microfibrils (12), said sheet-like particles (10) being of random shape and forming discontinuous walls surrounding voids (14), is provided by extensively beating a dilute aqueous dispersion of cellulose fibres and then freeze-drying the beaten pulp. 
<??>The pulp so treated is suitable for use in products such as sanitary napkins, tampons, diapers, dressings or the like which are used to absorb body fluids.
Patent IE-51300-B1 (IE)
Title: Protozoal growth-inhibiting diamines
IPC: A23K1/16
Filed: 1981-06-12
Abstract: Compounds of the formula  wherein R1 is hydrogen or carboxy; Y is -CH2F, -CHF2, -CF3 or -C IDENTICAL CH; and Z is -(CH2)3-NH2, -CH(CH)3- (CH2)2-NH2 or -CH=CH-CH2- NH2; with the proviso that, when R1 is hydrogen, Z is -CH(CH3)-(CH2)2- NH2 and Y is not -CF3; or a lactam thereof when R1 is carboxy; and their salts, are useful in inhibiting the growth of protozoa. They may be administered to animals, e.g. in their drinking water, and, if desired, together with an antiprotozoal agent.
Patent IE-56289-B1 (IE)
Title: Power station including an integrated coal gasification plant
IPC: F02C3/28
Filed: 1984-05-30
Abstract: Power generating station with an integrated coal gasification plant, with an air separation plant, a coal gasifier and a heat exchanger and dust removal plant connected to the coal gasifier, as well as with a gas turbine and steam power generating part connected to the heat exchanger and dust removal plant part. An ammonia synthesis plant is connected to the coal gasification plant with the interposition of a gas purification plant and a gas decomposition plant. Part of the exhaust gas produced in the ammonia synthesis can be fed as so-called purge gas to the combustion chamber of the gas turbine together with the gases separated in the gas purification plant and in the gas separation plant, and part of the dust-free raw gas of the coal gasifier.
Patent IE-34734-B1 (IE)
Title: Abrasive grinding elements
IPC: B24D3/02
Filed: 1970-11-16
Abstract: 1296589 Abrasive articles NORTON CO 12 Nov 1970 [14 Nov 1969] 53828/70 Heading C4V An abrasive element comprises diamond or cubic boron nitride abrasive grains bonded by a ceramic matrix which includes 23-53% by volume of total matrix of a filler which is graphite, hexagonal boron nitride or molybdenum disulphide or mixtures of these, optionally with up to 50% by volume of filler of a metal powder, the filler having a numerical average particle size of less than 200 microns and the element having less than 15% porosity per volume. The bond may be a devitrified glass containing microcrystalline particles, such as of alumina and silicon carbide.
[GB1296589A]
Patent IE-36879-B1 (IE)
Title: Cephalosporins
IPC: C07D499/00
Filed: 1972-11-22
Abstract: 1381339 Cephalosporins ELI LILLY & CO 22 Nov 1972 [30 Nov 1971 (2)] 53968/72 Heading C2C A process for preventing reversion of an imino halide of a 7-acylamidodesacetoxycephalosporinate ester of the formula where R is the residue of an acyl group and R 5 is the residue of an ester group, to a 7-acylamidodesacetoxycephalosporinate ester of the formula during treatment of the imino halide with an alcohol or thiol for the production of 7-aminodesacetoxycephalosporinate ester hydrohalides, comprises reacting the imino halide in an inert organic liquid diluent in the presence of hydrogen halide with alcohols or thiols of formulµ or wherein X represents 0 or 5; each of Y and Z is alkyl such that the alcohol or thiol has from 4 to 12 carbon atoms; or Y and Z are taken together with the carbon atom to which they are bonded to denote a cycloalkyl group having from 5 to 8 ring-forming carbon atoms; each of W and Z<SP>1</SP> is H or C 1 -C 2 alkyl, and each of R 1 and R 2 is H or a hydrocarbon moiety such that the 1,3-diol has from 3 to 15 carbon atoms; and each of R 3 and R 4 is H or alkyl such that the molecule has from 2 to 12 carbon atoms. The imino chloride of 4-nitrobenzyl 7-phenoxy-acetamido - 3 - methyl - 3 - cephem - 4 - carboxylate is prepared by reaction of 4-nitrobenzyl 7- phenoxyacetamido - 3 - methyl - 3 - cephem- 4-carboxylate with PCl 5 .
[GB1381339A]
Patent IE-54302-B1 (IE)
Title: Foaming surfactant compositions
IPC: A61K8/46
Filed: 1982-07-13
Abstract: Foaming compositions containing an alkylpolysaccharide surfactant and a sulfate, sulfonate and/or carboxylate cosurfactant and processes for utilizing foams containing these compositions.
Patent IE-68687-B1 (IE)
Title: Pure crystalline form of rifapentine
Inventor: NEBULONI MARINO
IPC: A61K31/495
Filed: 1991-06-28
Abstract: The present invention relates to the preparation of a new pure crystalline form of rifapentine, to the new pure crystalline form as such and to pharmaceutical formulations containing it.
Patent IE-48885-B1 (IE)
Title: Toothpaste
IPC: A61K8/25
Filed: 1979-11-28
Abstract: A toothpaste contains 2% by weight of calcium metasilicate, 0.80% of sodium monofluorophosphate and 44.77% calcium carbonate. The presence of calcium metasilicate in combination with the monofluorophosphate and carbonate increases the fluoride uptake over and above that which is expected from the level of free fluoride present.
Patent IE-58092-B1 (IE)
Title: Pesticidal substituted carbodiimides
IPC: A01N47/40
Filed: 1985-09-18
Abstract: The invention relates to novel substituted carbodiimides of the formula wherein R1 is hydrogen, halogen, C1-C10alkyl, C1-C5alkoxy, C1-C5alkoxy which is substituted by 1 to 7 halogen atoms, or is C1-C5alkylthio; R2 is hydrogen, halogen, C1-C10alkyl or C1-C5alkoxy; R3 is hydrogen, C1-C10alkyl, halogen, phenoxy, phenylthio, or is phenoxy or phenylthio, each mono- or disubstituted by a member selected from the group consisting of halogen, methyl, ethyl, C1-C3haloalkyl containing 1 to 7 halogen atoms and cyano, or is pyridyloxy or pyridyloxy which is mono- or disubstituted by a member selected from the group consisting of halogen and C1-C3haloalkyl containing 1 to 7 halogen atoms; R4 is C1-C12alkyl, alkoxyalkyl containing a total of 2 to 10 carbon atoms, C3-C10cycloalkyl, C3-C10cycloalkylmethyl, C3-C10cycloalkyl which is substituted by 1 to 3 C1-C3alkyl groups, or is C1-C5alkyl which is substituted to 1 or 2 C3-C10cycloalkyl groups, or is a polycyclic alkyl group containing 7 to 10 carbon atoms, phenyl(C1-C5)alkyl or phenyl(C1-C5)alkyl which is mono- or disubstituted at the phenyl nucleus by halogen, trifluoromethyl, methoxy or ethoxy, to the preparation of these compounds and to compositions containing them for use in pest control, especially for controlling insects and representatives of the order Acarina that attack plants and animals, in particular plant-destructive sucking insects.
Patent IE-51634-B1 (IE)
Title: Nonapeptide and decapeptide analogs of lhrh,useful as lhrh antagonists,methods of making them,and their pharmaceutical uses
IPC: C07K7/06
Filed: 1981-10-05
Abstract: Nonapeptide and decapeptide analogs of LHRH which have the formulaand the pharmaceutically acceptable salts thereof, wherein:X is a D-alanyl residue wherein one hydrogen on C-3 is replaced by:a) a carbocyclic aryl-containing radical selected from the group consisting of phenyl substituted with three or more straight chain lower alkyl groups, naphthyl, anthryl, fluorenyl, phenanthryl, biphenylyl and benzhydryl; orb) a saturated carbocyclic radical selected from the group consisting of cyclohexyl substituted with three or more straight chain lower alkyl groups, perhydronaphthyl, perhydrobiphenylyl, perhydro-2,2-diphenylmethyl, and adamantyl; orc) a heterocyclic aryl containing radical selected from the group consisting of radicals represented by the following structural formulas:wherein A" and A' are independently selected from the group consisting of hydrogen, lower alkyl, chlorine, and bromine, and G is selected from the group consisting of oxygen, nitrogen, and sulfur;A is an aminoacyl residue selected from the group consisting of L-pyroglutamyl, D-pyroglutamyl, N-acyl-L-prolyl, N-acyl-D-prolyl, N-acyl-D-tryptophanyl, N-acyl-D-phenylalanyl, N-acyl-D-p-halophenylalanyl, and N-acyl-X wherein X is as defined previously;B is an amino acyl residue selected from the group consisting of D-phenylalanyl, D-p-halophenylalanyl, 2,2-diphenylglycyl, and X wherein X is as defined previously;C is an amino acyl residue selected from the group consisting of L-tryptophanyl, D-tryptophanyl, D-phenylalanyl and X wherein X is as defined above;E is glycinamide or -NH-R<sup>1</sup>, wherein R<sup>1</sup> is lower alkyl, cycloalkyl, fluoro lower alkyl orR<sup>2</sup> is hydrogen or lower alkyl;are disclosed. These compounds are LHRH antagonists.
Patent IE-56087-B1 (IE)
Title: Bifocal contact lens having diffractive power
IPC: G02B27/42
Filed: 1983-10-17
Abstract: A bifocal contact lens has diffractive power added to the basic refractive power provided by the material of the lens (2) and the basic curvature of its front and rear surfaces (3 and 1). The diffractive power arises from concentric zones, each providing an asymmetric retardation of light across the zone width to direct design wavelength light predominantly into a required order and sign of diffraction, while other wavelength light is predominantly transmitted at zero order. Design wavelength light from an object at one distance can then be focused by way of diffraction of that order and sign, and other wavelength light from an object at another distance can be focused by way of zero order transmission. Preferably the zones are defined, and the asymmetric retardation provided, by a rear surface contour having steps but which approximates to the required basic curvature.
Patent IE-46356-B1 (IE)
Title: Process and apparatus for controlling the quantity of impreganting or coating substance deposited on linear materials
IPC: C03B37/10
Filed: 1977-12-20
Abstract: Impregnated or coated linear material, for example, coated glass fibers, are dried in one or more calibrated spaces which control the percentage of impregnate or coating. A sweeping device moves the material laterally assuring complete sweeping and hence self-cleaning of the calibrated spaces.
Patent IE-58895-B1 (IE)
Title: Antimicrobial additives for compound animal feedstuffs
IPC: A23K3/00
Filed: 1986-10-01
Abstract: The present invention relates to animal feed preservative compositions containing a binary blend of formic acid and propionic acid, the amount of propionic acid in the blend being from 1-25% w/w of the total blend. Surprisingly, the , proposed blend is more effective at controlling salmonella, especially in poultry, than formic acid when used alone.
Patent IE-64635-B1 (IE)
Title: Pharmaceutical combination preparations for use in anti-neoplastic therapy
Inventor: GRUNICKE HANS HERMANN
IPC: A61K45/06
Filed: 1989-08-17
Abstract: The present invention relates to pharmaceutical combinations for use in antineoplastic therapy. The products contain as active substances compounds which inhibit protein kinase C, in combination with lipids, lipid analogues, cytostatics or compounds which inhibit phospholipases.
Patent IE-57085-B1 (IE)
Title: Pouring insert for a container
IPC: B65D47/06
Filed: 1985-10-25
Abstract: A pouring insert for a container closable by a cup-shaped dosing, metering or proportioning cap 4 is cup-shaped and has at least 3 uniformly, circumferentially distributed openings 11 extending into the side wall and into the base area 10, of the cup-shaped insert. The base area is convex in the direction of the open end of the insert, so providing an annular region 10 into which the openings, in the form of six slots, extend. The insert is sealingly located in the container neck by means either of an outwardly directed annular shoulder 6 and a sealing face 12 or by a outer skirt extending over the outside of the container neck (26, Figure 2A). The dosing cup nests within the pouring insert and screws either into the insert (Figure 2A) or into the neck exterior by means of an outer skirt 5.
Patent IE-66310-B1 (IE)
Title: Oval wrap suture package
Inventor: KALINSKI ROBERT J
IPC: A61B17/06
Filed: 1989-08-22
Abstract: A molded two-piece (12, 14) suture package is disclosed which encloses and defines an oval channel (30) in which sutures (60) may be wound. The oval channel (30) has two semicircular end sections (32, 33) connected by straight side sections (34). An opening (38) in the channel (30) is provided at the juncture of a straight section (34) and an end section (33), permitting sutures (60) to be withdrawn from the channel (30) at the end of a straight section (34). In a preferred embodiment the interior wall of the channel (30) is formed by alternating engaging sections (32-36) formed in the respective package pieces (12, 14). To prevent the wrapped suture (60) from becoming entrapped when the two pieces (12, 14) are engaged, the top and bottom of the channel (30) is alternately raised (26', 30') and lowered (26'', 30'') in alignment with the alternating wall sections, causing the wound suture (60) to bridge those areas where it may become entrapped between the mating package pieces (12, 14). Entrapment of the suture (60) end at the outside of the channel (30) is prevented by alternately recessing the outer wall of the channel (30). Flexible molded needle (70) parks are also disclosed for the package.
Patent IE-42762-B1 (IE)
Title: Electric furnace for melting glass
IPC: C03B5/027
Filed: 1975-12-15
Abstract: 1506060 Internal resistance heating of glass STATNI VYZKUMNY USTAV SKLARSKY 22 Dec 1975 [20 Dec 1974] 52312/75 Heading H5H [Also in Division H2] In a glass melting furnace having a melting space 2 and a holding space 3 interconnected by passages 5 through a separating wall 4, vertical electrodes built in the base of the melting section are arranged in rows 6, 7, 8, 9; within each row, the electrodes are arranged in groups 61, 62, 63 etc., the electrode or electrodes of each group being connected to a particular terminal 10, 11, 12, 13 &c. of a source of multiphase current, 14 &c., such that all electrodes of a row will be in phase and the electrodes nearest to passages 5 will be at a higher voltage than those further away (to give stronger heating and hence stronger vertical convection currents adjacent the wall than elsewhere); further, the "equivalent diameter" of the passage or passages lies between 0À2 and 0À3 of that of the cross-section of the melting space in a plane perpendicular to its length. The "equivalent diameter" of each passage or the melting space is defined as 4 Î area of crosssection ¸ circumference. By this means, a flow of relatively cool molten glass returning from the holding section will keep the base of the furnace cool, heat will be generated more uniformly throughout the melting section and a more uniform glass will be produced.
Patent IE-42458-B1 (IE)
Title: Syn-7-(2-hydroxyiminoacetamido)-3-pyridiniummethyl-cephalosporins, methods for their preparation and compositions containing them
IPC: C07D501/46
Filed: 1975-12-19
Abstract: Compounds with antibiotic activity and the formula I in which the symbols B, R<1>, R<2> and R<3> have the meaning stated in Claim 1, are prepared in the form of the syn isomer or a mixture of syn isomer and anti isomer, where the content of the syn isomer is at least 90%, by reacting a corresponding ceph-3-em-4-carboxylic acid which is substituted in position 3 by a group -CH2X where X is a substituent which can be replaced by the pyridine residue, where appropriate with intermediate protection of the 4-carboxyl group, with an R<3>-substituted pyridine and, if the precursor has an R<1>COCONH group in position 7, converting the resulting compound into the corresponding ceph-3-em compound I by reaction with a hydroxylamine R<2>ONH2. Resulting compounds I in which B is &rdurule& S->O can subsequently be reduced to the corresponding, preferred, compounds in which B is &rdurule& S. In another process, the resulting carboxylic acids (I) are esterified. The compounds are distinguished by an antibiotic activity with a broad spectrum of action, especially by a high activity against Gram-negative microorganisms including those which produce beta -lactamases, and furthermore have a high stability to beta -lactamases produced by some Gram-negative organisms, and to esterases.
Patent IE-57305-B1 (IE)
Title: New pharmacologically active pyrazolopyridines
IPC: A61K31/44
Filed: 1983-12-19
Abstract: The present invention is directed to new 4,7-dihydro-pyrazolo[3,4-b]pyridines. The compounds possess Ca2+-antagonist, antihypertensive, vasodilating and antiangina activity. A process for producing them as well as pharmaceutical compositions containing them are also described.
Patent IE-75735-B1 (IE)
Title: Excitatory amino acid antagonists
Inventor: HAMILTON GREG SCOTT
IPC: A61P25/28
Filed: 1991-12-06
Abstract: An unexpectedly more potent isomer of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid, a known excitatory amino acid antagonist, pharmaceutical compositions including this isomer and methods of using this isomer to antagonize excitatory amino acid receptors.
Patent LU-100318-B1 (LU)
Title: Capacitive Occupant Detection System with Improved Discrimination Capability
Inventor: ALTHAUS FRANK
IPC: B60R21/015
Filed: 2017-06-15
Granted: 2018-12-18
Abstract: A capacitive seat occupancy detection and classification system (10) with a capacitive sensor having at least two distinct antenna electrodes (18, 20) and a method of operating is proposed to reduce an impact of the sensor-to-object impedance Zso on an object-to-ground impedance ZOG measurement that the system performs. By measuring the impedance between the different antenna electrodes by the system, additional information is obtainable that can be used to compensate the impact of the sensor-to-object impedance Zso on the object-to-ground impedance. As one effect of combining both impedance measurement results, the proposed system is able to determine the object-to-ground impedance ZOG completely independent from wear of ISOFIX anchorages or human objects touching the electric ground of the vehicle, thus ensuring a stable classification of the object over the entire vehicle lifetime. The method further enables high-resolution seat occupancy classification.
Patent LU-101515-B1 (LU)
Title: Anordnung und Verfahren zum Darstellen von medizinischen Alarmen
Inventor: ISE EDGAR
IPC: A61B5/145
Filed: 2019-12-06
Granted: 2021-06-08
Abstract: Die Erfindung bezieht sich auf eine Anordnung umfassend ein medizinisches Gerät mit Patienten-Sensoren, eine Signalverarbeitungseinheit und eine Ausgabeeinheit. Die Signalverarbeitungseinheit empfängt Messwerte von den Patienten-Sensoren und erzeugt durch Auswertung von empfangenen Messwerten mehrere Signale. Die Signalverarbeitungseinheit entscheidet, ob ein vorgegebenes Alarm-Kriterium erfüllt ist, welches sich auf ein Signal bezieht, und detektiert einen Alarm sowie den Zeitpunkt des Alarms. Die Signalverarbeitungseinheit steuert die Ausgabeeinheit an. Die angesteuerte Ausgabeeinheit stellt in einer Alarm-Gesamt-Abfolge (16) die Alarme in einem Gesamt-Zeitraum (T) sowie in einem Alarm-Referenz-Abschnitt (26) und in einer Alarm-Referenz-Abfolge (18) die Alarme in einem Referenz-Zeitfenster (T1) und in einer Signalverlaufs-Darstellung (10) den zeitlichen Verlauf mindestens eines Signals im Referenz-Zeitfenster dar. Das Referenz-Zeitfenster ist ein Abschnitt des Gesamt-Zeitraums. Die angesteuerte Ausgabeeinheit stellt die zeitliche Positionierung des Alarm-Referenz-Abschnitts relativ zu der Alarm-Gesamt-Abfolge dar. Die Zeitmaßstäbe für die Signalverlaufs-Darstellung und die Alarm-Referenz-Abfolge sind feiner als die Zeitmaßstäbe für die Alarm-Gesamt-Abfolge und den Alarm-Referenz-Abschnitt.
Patent LU-500173-B1 (LU)
Title: Fresh-keeping Method for Inhibiting Apple Browning and Prolonging Storage Time
Inventor: WANG WENHUI
IPC: A23B7/157
Filed: 2021-05-19
Granted: 2021-11-19
Abstract: A fresh-keeping method for inhibiting apple browning and prolonging the storage time, comprising the following steps : sprinkle treatment with 1-Methylcyclopropene (1-MCP) aqueous solution before apple harvest; then picking 80% to 90% ripe apples of uniform size and peel colour, free of bumps; shortening the fruit stems and soaking them in the calcium chloride solution, then taking them out and drying them; covering the fruit with foam net and placing them in a cardboard or plastic fruit box lined with a polyethylene (PE) film fresh-keeping bag for apples, which is placed open; placing the gauze-wrapped soda lime in the fresh-keeping bag and finally, cooling the fruit to -2~-1? slowly for normal management. During storage, the oxygen concentration in the bag is controlled at 19%~21%, the carbon dioxide concentration is controlled at 0.3% or less, the ethylene concentration is controlled at 5?L/L or less and the relative humidity is 85%~90%.
Patent LU-500790-B1 (LU)
Title: Molecular structure and synthesis method of a novel anti-triple-negative breast cancer drug
Inventor: CHEN YUEHUA
IPC: C07K14/00
Filed: 2021-10-27
Granted: 2022-04-27
Abstract: The present invention discloses the molecular structure and synthesis method of a novel anti- triple-negative breast cancer drug, the molecular structure is pHLIP(Var7)- P1AP, among which pHLIP(Var7)- AEEQNPWARYLEWLFPTETLLLELC, P1AP- CKKSRALF, the synthesis method is as follows: 1) synthesize pHLIP(Var7)Cys peptide sequence by solid-phase peptide synthesis method: AEEQNPWARYLEWLFPTETLLLELC; 2) synthesis of Cys P1AP peptide sequence by solid-phase peptide synthesis method: CKKSRALF; 3) pHLIP(Var7)Cys and CysP1AP are connected by disulfide bonds to obtain the pHLIP(Var7)- P1AP sequence: AEEQNPWARYLEWLFPTETLLLELC-CKKSRALF; the present invention can specifically insert the C-terminus of pHLIP(Var7)- P1AP into triple- negative breast cancer cells, the disulfide bonds cleavage release P1AP into tumor cells, P1AP can perform the intracellular part of the receptor through targeting tumor cells PAR1 to achieve the purpose of inhibiting tumor cells proliferation.
Patent LU-501106-B1 (LU)
Title: Multifunctional sampling device for environmental monitoring and method thereof
Inventor: LIU ZHONGCHUANG
IPC: G05D1/10
Filed: 2021-12-28
Granted: 2022-06-28
Abstract: A multifunctional sampling device for environmental monitoring. The sampling device is arranged on an unmanned aerial vehicle; the unmanned aerial vehicle comprises a flight control system used for controlling a flight route of the unmanned aerial vehicle; each sampler comprises a control end and a sampling end; the control end is composed of a control system used for controlling the sampler, an analysis system used for analyzing a signal received by the sampling end, and a display system used for displaying the analysis result; the sampling end is connected with a sampling quantity sensor by a processing system; the sampling quantity sensor is connected with the corresponding sampler; the control end is interconnected with the sampling end through a communication system to realize information and signal transmission between the sampling end and the control end. The water, the air, and the soil can be simultaneously sampled on one device.